Literature DB >> 11451599

Topical use of Sucralfate Cream in second and third degree burns.

A Banati1, S R Chowdhury, S Mazumder.   

Abstract

This clinical study was undertaken to test the efficacy of topical Sucralfate Cream in second and third degree burns. Topical Sucralfate Cream has been used on a wide variety of lesions from radiation proctitis and dermatitis to keratoconjunctivitis with remarkable results. The study was carried out in two phases. The first phase comprised 60 patients, 30 of whom were treated with Sucralfate Cream while the other 30 were treated with other topical antimicrobial agents. Twenty-one of the patients in the study group had second-degree burns and nine patients' third degree burns. In the second phase, a double blind study was carried out on 25 patients where one area of burns was treated with Sucralfate Cream while another control area of the same patient was treated with a placebo ointment, containing the excipients used during preparation of the Sucralfate Cream, without Sucralfate. In the first phase, it was seen that the period of epithelialisation of second degree burns in the study group treated with Sucralfate Cream was 18.8 days compared with 24.6 days with other topical agents. This difference is statistically significant with a P value of <0.00001. In the double blind study, also healing in the areas treated with Sucralfate was more rapid than those treated with bland placebo ointment. The difference in the two rates of healing was statistically significant with a P value of 0.00067. Histopathological studies were also carried out in 10 patients of phase I of the trial. Sucralfate Cream promotes rapid epithelialisation of second degree burns with minimal said effects and offers another topical agent in the burn care specialist's armamentarium.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11451599     DOI: 10.1016/s0305-4179(00)00165-0

Source DB:  PubMed          Journal:  Burns        ISSN: 0305-4179            Impact factor:   2.744


  7 in total

1.  Efficacy of 10% sucralfate ointment in the reduction of acute postoperative pain after open hemorrhoidectomy: a prospective, double-blind, randomized, placebo-controlled trial.

Authors:  Shahram Ala; Majid Saeedi; Fariborz Eshghi; Mohamadreza Rafati; Vahid Hejazi; Roja Hadianamrei
Journal:  World J Surg       Date:  2013-01       Impact factor: 3.352

2.  Comparison of topical sucralfate with dexpanthenol in rat wound model.

Authors:  Eda Yildizhan; Burak Veli Ulger; Murat Akkus; Dilara Akinci; Omer Basol
Journal:  Int J Exp Pathol       Date:  2022-04-20       Impact factor: 2.793

3.  Therapeutic paint of cidofovir/sucralfate gel combination topically administered by spraying for treatment of orf virus infections.

Authors:  Fabio Sonvico; Gaia Colombo; Laura Gallina; Fabrizio Bortolotti; Alessandra Rossi; Colin J McInnes; Gina Massimo; Paolo Colombo; Alessandra Scagliarini
Journal:  AAPS J       Date:  2009-04-21       Impact factor: 4.009

4.  Efficacy of sucralfate ointment in the prevention of acute proctitis in cancer patients: A randomized controlled clinical trial.

Authors:  Sara Saei; Adeleh Sahebnasagh; Arash Ghasemi; Jafar Akbari; Abbas Alipour; Hossein Lashkardoost; Ali Yaghobi Joybari; Farid Nejad Dadgar; Shahram Ala; Ebrahim Salehifar
Journal:  Caspian J Intern Med       Date:  2020

5.  Efficacy of topical sucralfate vERSUs silver sulfadiazine in the management of burns: A 1-year randomized controlled trial.

Authors:  A S Godhi; P Ram; R Powar
Journal:  J West Afr Coll Surg       Date:  2017 Jan-Mar

6.  A novel dermo-cosmetic product containing thermal spring water, sucralfate, copper sulfate, and zinc sulfate in the management of hand eczema.

Authors:  Virginie Ribet; Ewa Mielewczyk; Anne Sirvent; Victor Georgescu; Ana Beatris Rossi
Journal:  Clin Cosmet Investig Dermatol       Date:  2018-07-16

7.  Randomized controlled trial of topical mupirocin versus mupirocin with sucralfate combination in chronic skin ulcers.

Authors:  Subhrangsu Chatterjee; Sumit Sen; Avijit Hazra; Amal Kanti Das
Journal:  Indian J Pharmacol       Date:  2019-11-26       Impact factor: 1.200

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.